148 related articles for article (PubMed ID: 11704380)
1. Echo-Doppler mitral flow monitoring: an operative tool to evaluate day-to-day tolerance to and effectiveness of beta-adrenergic blocking agent therapy in patients with chronic heart failure.
Capomolla S; Pinna GD; Febo O; Caporotondi A; Guazzotti G; La Rovere MT; Gnemmi M; Mortara A; Maestri R; Cobelli F
J Am Coll Cardiol; 2001 Nov; 38(6):1675-84. PubMed ID: 11704380
[TBL] [Abstract][Full Text] [Related]
2. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure.
Pozzoli M; Traversi E; Cioffi G; Stenner R; Sanarico M; Tavazzi L
Circulation; 1997 Mar; 95(5):1222-30. PubMed ID: 9054853
[TBL] [Abstract][Full Text] [Related]
3. Restrictive left ventricular filling pattern and its effect on the clinical course of systolic heart failure in patients receiving carvedilol.
Nessler J; Nessler B; Kitliński M; Stepniewski M; Piwowarska W
Cardiol J; 2008; 15(4):329-37. PubMed ID: 18698541
[TBL] [Abstract][Full Text] [Related]
4. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
[TBL] [Abstract][Full Text] [Related]
5. Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure.
Traversi E; Pozzoli M; Cioffi G; Capomolla S; Forni G; Sanarico M; Tavazzi L
Am Heart J; 1996 Oct; 132(4):809-19. PubMed ID: 8831371
[TBL] [Abstract][Full Text] [Related]
6. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure.
Mortara A; La Rovere MT; Pinna GD; Maestri R; Capomolla S; Cobelli F
J Am Coll Cardiol; 2000 Nov; 36(5):1612-8. PubMed ID: 11079666
[TBL] [Abstract][Full Text] [Related]
7. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
[TBL] [Abstract][Full Text] [Related]
8. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.
Arslan S; Erol MK; Bozkurt E; Acikel M; Gundogdu F; Atesal S; Senocak H
Int J Cardiovasc Imaging; 2007 Oct; 23(5):549-55. PubMed ID: 17171429
[TBL] [Abstract][Full Text] [Related]
9. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
[TBL] [Abstract][Full Text] [Related]
10. Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure.
Palazzuoli A; Carrera A; Calabria P; Puccetti L; Pastrorelli M; Pasqui AL; Auteri A; Bruni F
Am Heart J; 2004 Jan; 147(1):E2. PubMed ID: 14691440
[TBL] [Abstract][Full Text] [Related]
11. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
Maack C; Elter T; Nickenig G; LaRosee K; Crivaro M; Stäblein A; Wuttke H; Böhm M
J Am Coll Cardiol; 2001 Oct; 38(4):939-46. PubMed ID: 11583862
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD
Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433
[TBL] [Abstract][Full Text] [Related]
13. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure.
Krum H; Ninio D; MacDonald P
Heart; 2000 Dec; 84(6):615-9. PubMed ID: 11083738
[TBL] [Abstract][Full Text] [Related]
14. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
15. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
[TBL] [Abstract][Full Text] [Related]
16. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol: a review of its use in chronic heart failure.
Keating GM; Jarvis B
Drugs; 2003; 63(16):1697-741. PubMed ID: 12904089
[TBL] [Abstract][Full Text] [Related]
18. Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker for predicting cardiac events and evaluating the effectiveness of carvedilol treatment in patients with chronic systolic heart failure.
Susa T; Kobayashi S; Tanaka T; Murakami W; Akashi S; Kunitsugu I; Okuda S; Doi M; Wada Y; Nao T; Yamada J; Ueyama T; Okamura T; Yano M; Matsuzaki M
Circ J; 2012; 76(1):117-26. PubMed ID: 22008315
[TBL] [Abstract][Full Text] [Related]
19. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
20. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
